SCHEDULE: Cormorant Asset Management Boosts Bright Minds Stake

Cormorant Asset Management and Bihua Chen report a 10.88% beneficial ownership stake in Bright Minds Biosciences Inc. common shares.

Summary

• Cormorant Asset Management, LP and Bihua Chen have filed an Amendment No. 2 to Schedule 13G, reporting their beneficial ownership in Bright Minds Biosciences Inc.
• The reporting persons collectively beneficially own 1,059,331 Common Shares of Bright Minds Biosciences Inc.
• This ownership represents 10.88% of the total class of securities outstanding.
• Cormorant Asset Management, LP, a Delaware limited partnership, serves as the investment adviser to the Cormorant Funds, which directly hold these shares.
• Bihua Chen is the managing member of Cormorant Global Healthcare GP, LLC, the general partner of the Master Fund, and the general partner of Cormorant Asset Management, LP.
• The percentage of class is calculated based on 9,732,161 Common Shares outstanding following a public offering that closed on January 9, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive disclosure, primarily due to the transparency of a significant institutional stake, which can be interpreted as a vote of confidence, without providing new operational insights.

Positives

• A significant institutional investor, Cormorant Asset Management, LP, holds a substantial 10.88% beneficial ownership stake in Bright Minds Biosciences Inc., which can signal confidence in the company's prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or operations.

Industry Context

StockSavvy.ai notes that institutional filings like this Schedule 13G provide transparency into significant holdings by major investment firms. Such disclosures can influence market perception, particularly in the biotechnology sector where investor confidence and the backing of specialized funds like Cormorant Asset Management are often closely watched indicators of potential value.

Stakeholder Impact

• Shareholders gain transparency regarding the significant ownership stake held by Cormorant Asset Management, LP and Bihua Chen, which may influence investor sentiment.

Key Dates

Recommendation

The Schedule 13G filing indicates a substantial institutional ownership by Cormorant Asset Management, LP and Bihua Chen, holding 10.88% of Bright Minds Biosciences Inc. common shares. While this signals confidence from a notable investor, the filing itself does not provide operational or financial performance data to warrant a 'buy' or 'sell' recommendation. A 'hold' is appropriate as investors should monitor future company developments and financial reports for a more comprehensive investment decision.

Keywords

Bright Minds Biosciences, Cormorant Asset Management, Bihua Chen, Schedule 13G, beneficial ownership, common shares, institutional investment, equity stake